文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Glioblastoma: synergy of growth promotion between CCL5 and NK‐1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti‐HIV drug and blocking NK‐1R with aprepitant, an FDA approved anti‐nausea drug
复制论文ID
分享
摘要
作者
参考文献
暂无分享,去
创建一个
R. Kast
保存到论文桶